Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science
Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science is offered by National Institutes of Health. Max award: Not specified. This is a forecast; the deadline is not set yet.
| Opportunity number | PAR-28-006 |
|---|---|
| Agency | National Institutes of Health |
| Status | Forecasted |
| Posted | Jul 20, 2026 |
| Closes | Not set |
| Award ceiling | Not specified |
| Award floor | Not specified |
| Total program funding | Not specified |
| Expected awards | Not specified |
| Who can apply | Others (see text field entitled "Additional Information on Eligibility" for clarification) |
| Category | Health |
Summary (excerpt)
The purpose of the Congressionally mandated Clinical and Translational Science Award (CTSA) Program is to accelerate the translation of scientific discoveries into treatments, diagnostics, and health interventions that improve patient and public health by funding and coordinating a national network of academic medical centers that provide the infrastructure, expertise, training, and collaboration needed to move discoveries from the laboratory int…
View the official listing and apply on Grants.gov
Before you apply
- Register your organization in SAM.gov and get a UEI — it can take weeks
- Create a Grants.gov account and check eligibility in the full notice (NOFO)
- Start early; the system gets busy near deadlines
Grants closing soon · More from National Institutes of Health